New Key Statistics Module, Z-Score and F-Score
NAS:BIOR Key Ratios
| Market Cap $ M | 26.24 |
| Enterprise Value $ M | 61.46 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 38.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -7.12 |
| Beneish M-Score | -7.16 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 31.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.61 |
| EV-to-EBITDA | -0.61 |
| PEG | -- |
| Shares Outstanding M | 35.94 |
| Net Margin (%) | -20,379.23 |
| Operating Margin % | -12,337.32 |
| Pre-tax Margin (%) | -20,427.21 |
| Quick Ratio | 0.28 |
| Current Ratio | 0.28 |
| ROA % (ttm) | -288.97 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -152.24 |
| Dividend Yield % | -- |
| Altman Z-Score | -74.48 |
BIOR Number of Guru Trades
BIOR Volume of Guru Trades
Gurus Latest Trades with NAS:BIOR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BIOR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biora Therapeutics Inc Insider Transactions
No Available Data
News about NAS:BIOR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers